Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studies

3 Feb 2023

Abstract excerpt

BACKGROUND: The ability of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to decrease certain microvascular events has called for the investigation of GLP-1 RAs against diabetic retinopathy (DR), but the evidence is limited. By combining data from observational and Mendelian randomization (MR) studies, we aimed to investigate whether GLP-1 RAs decrease the risk of DR. METHODS: We combined data from several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Pancreatic function and diabetes
Share to Retinal Diseases and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36737746
DOI: 10.1186/s12916-023-02753-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glucagon-like peptide-1 receptor agonists and diabetic retinopathy: nationwide cohort and Mendelian randomization studiesPMID 36737746Read ↗

Relationship between remnant cholesterol and the risk of diabetic microvascular complications in type 2 diabetes: An observational studySemantic proximity Read ↗

Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization studySemantic proximity Read ↗

Genetic Association between Lipid-Regulating Drug Targets and Diabetic Retinopathy: A Drug Target Mendelian Randomization StudySemantic proximity Read ↗

The Causal Relationship and Association between Biomarkers, Dietary Intake, and Diabetic Retinopathy: Insights from Mendelian Randomization and Cross-Sectional StudySemantic proximity Read ↗

Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study.Semantic proximity Read ↗

BMI and plasma lipid levels with risk of proliferative diabetic retinopathy: a univariable and multivariable Mendelian randomization studySemantic proximity Read ↗

The causal effect of obesity on diabetic retinopathy: A two-sample Mendelian randomization studySemantic proximity Read ↗

Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational studySemantic proximity Read ↗

Diabetic retinopathy risk in patients with unhealthy lifestyle: A Mendelian randomization studySemantic proximity Read ↗

Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.Semantic proximity Read ↗

Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized WorldSemantic proximity Read ↗

Causal Evaluation of Laboratory Markers in Type 2 Diabetes on Cancer and Vascular Diseases Using Various Mendelian Randomization ToolsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.